Have a feature idea you'd love to see implemented?
Let us know!
PODD Insulet Corp
Price (delayed)
$231.84
Market cap
$16.26B
P/E Ratio
41.03
Dividend/share
N/A
EPS
$5.65
Enterprise value
$16.83B
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod
Highlights
PODD's price to earnings (P/E) is 99% lower than its 5-year quarterly average of 2816.4 and 35% lower than its last 4 quarters average of 63.2
The equity has soared by 80% YoY and by 26% QoQ
Insulet's quick ratio has increased by 13% YoY but it has decreased by 2.8% from the previous quarter
Key stats
What are the main financial stats of PODD
Market
Valuations
Earnings
Shares outstanding
70.12M
Market cap
$16.26B
Enterprise value
$16.83B
Price to earnings (P/E)
41.03
Price to book (P/B)
16.26
Price to sales (P/S)
8.67
EV/EBIT
54.95
EV/EBITDA
44.09
EV/Sales
8.99
Revenue
$1.87B
EBIT
$306.3M
EBITDA
$381.8M
Free cash flow
$157.3M
Per share
Balance sheet
Liquidity
EPS
$5.65
Free cash flow per share
$2.25
Book value per share
$14.25
Revenue per share
$26.73
TBVPS
$38.99
Total assets
$2.88B
Total liabilities
$1.88B
Debt
$1.4B
Equity
$998.4M
Working capital
$1.26B
Debt to equity
1.4
Current ratio
3.6
Quick ratio
2.41
Net debt/EBITDA
1.51
Margins
Efficiency
Dividend
EBITDA margin
20.4%
Gross margin
69%
Net margin
21.1%
Operating margin
14.6%
Return on assets
15%
Return on equity
50.5%
Return on invested capital
11.3%
Return on capital employed
12.8%
Return on sales
16.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PODD stock price
How has the Insulet stock price performed over time
Intraday
1.09%
1 week
-0.34%
1 month
5.8%
1 year
60.31%
YTD
6.85%
QTD
-0.39%
Financial performance
How have Insulet's revenue and profit performed over time
Revenue
$1.87B
Gross profit
$1.29B
Operating income
$272.7M
Net income
$395.3M
Gross margin
69%
Net margin
21.1%
The company's operating margin has surged by 152% YoY and by 4.3% QoQ
PODD's net income has surged by 69% since the previous quarter
The company's net margin has surged by 61% QoQ
PODD's gross profit is up by 42% YoY and by 5% from the previous quarter
Growth
What is Insulet's growth rate over time
Valuation
What is Insulet stock price valuation
P/E
41.03
P/B
16.26
P/S
8.67
EV/EBIT
54.95
EV/EBITDA
44.09
EV/Sales
8.99
PODD's price to earnings (P/E) is 99% lower than its 5-year quarterly average of 2816.4 and 35% lower than its last 4 quarters average of 63.2
The EPS has soared by 69% from the previous quarter
The equity has soared by 80% YoY and by 26% QoQ
PODD's price to book (P/B) is 63% less than its 5-year quarterly average of 44.2 and 4.9% less than its last 4 quarters average of 17.1
PODD's price to sales (P/S) is 39% lower than its 5-year quarterly average of 14.1 but 14% higher than its last 4 quarters average of 7.6
PODD's revenue is up by 28% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is Insulet business performance
Insulet's return on invested capital has surged by 163% YoY and by 6% QoQ
The ROS has soared by 125% YoY and by 3.1% from the previous quarter
The return on assets has surged by 61% since the previous quarter
PODD's ROE is up by 45% QoQ
Dividends
What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PODD.
Financial health
How did Insulet financials performed over time
The total assets is 53% higher than the total liabilities
The total assets rose by 21% YoY and by 10% QoQ
Insulet's quick ratio has increased by 13% YoY but it has decreased by 2.8% from the previous quarter
The company's debt is 40% higher than its equity
The equity has soared by 80% YoY and by 26% QoQ
The debt to equity has decreased by 44% YoY and by 21% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.